(HLNE) Hamilton Lane - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4074971064

HLNE: Private Equity, Venture Capital, Alternative Investments, Funds

Hamilton Lane Incorporated (NASDAQ:HLNE) is a leading global alternative investment manager with a strong focus on private equity, venture capital, and alternative investment strategies. Founded in 1991 and headquartered in Conshohocken, Pennsylvania, the firm has established itself as a trusted partner for institutional investors, family offices, and high-net-worth individuals seeking access to the private markets.

HLNE specializes in a wide range of investment strategies, including direct credit, direct equity, fund of funds, evergreen funds, and real assets. The firm’s expertise spans multiple geographies, with a presence in key markets across North America, Europe, Asia Pacific, and the Middle East. This global reach allows Hamilton Lane to identify and capitalize on emerging opportunities while managing risk effectively.

The firm’s investment approach is highly diversified, both in terms of sectors and geographies. It targets sectors such as energy, industrials, healthcare, technology, consumer discretionary, and financials, among others. Geographically, HLNE invests across Africa/Middle East, Asia/Pacific, Europe, Latin America, the United States, and Canada, demonstrating a broad and balanced approach to portfolio construction.

Hamilton Lane is known for its ability to invest across the entire private market spectrum, from early-stage venture capital to mature buyouts. The firm’s typical investment size ranges from $1 million to $100 million, with a preference for small- to mid-sized enterprises. It often seeks majority stakes, reflecting its confidence in its due diligence and strategic alignment with portfolio companies.

As a publicly traded company, HLNE offers investors a unique opportunity to gain exposure to the private markets through its stock. With a market capitalization of approximately $8.65 billion and a price-to-earnings ratio of 28.06, the firm is valued for its consistent performance and strong track record. Its price-to-book ratio of 10.13 reflects the market’s confidence in its ability to generate returns and manage alternative assets effectively.

Hamilton Lane’s reputation as a leader in alternative investments is built on its long-term performance, rigorous research, and collaborative approach with its clients. For investors and fund managers, HLNE represents a compelling option for diversifying portfolios and accessing the private markets through a proven and experienced platform.

Additional Sources for HLNE Stock

HLNE Stock Overview

Market Cap in USD 8,723m
Sector Financial Services
Industry Asset Management
GiC Sub-Industry Asset Management & Custody Banks
IPO / Inception 2017-03-01

HLNE Stock Ratings

Growth 5y 80.6%
Fundamental 70.8%
Dividend 66.4%
Rel. Strength Industry 12.7
Analysts 2.86/5
Fair Price Momentum 153.42 USD
Fair Price DCF 76.72 USD

HLNE Dividends

Dividend Yield 12m 1.36%
Yield on Cost 5y 4.43%
Annual Growth 5y 9.54%
Payout Consistency 100.0%

HLNE Growth Ratios

Growth Correlation 3m -19.9%
Growth Correlation 12m 76.6%
Growth Correlation 5y 70.9%
CAGR 5y 26.33%
CAGR/Max DD 5y 0.54
Sharpe Ratio 12m 0.78
Alpha 23.29
Beta 1.31
Volatility 42.72%
Current Volume 585.2k
Average Volume 20d 551.5k
What is the price of HLNE stocks?
As of March 16, 2025, the stock is trading at USD 142.56 with a total of 585,176 shares traded.
Over the past week, the price has changed by -1.97%, over one month by -8.40%, over three months by -14.60% and over the past year by +35.97%.
Is Hamilton Lane a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Hamilton Lane (NASDAQ:HLNE) is currently (March 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 70.84 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HLNE as of March 2025 is 153.42. This means that HLNE is currently overvalued and has a potential downside of 7.62%.
Is HLNE a buy, sell or hold?
Hamilton Lane has received a consensus analysts rating of 2.86. Therefor, it is recommend to hold HLNE.
  • Strong Buy: 0
  • Buy: 0
  • Hold: 6
  • Sell: 1
  • Strong Sell: 0
What are the forecast for HLNE stock price target?
According to ValueRays Forecast Model, HLNE Hamilton Lane will be worth about 172.5 in March 2026. The stock is currently trading at 142.56. This means that the stock has a potential upside of +20.99%.
Issuer Forecast Upside
Wallstreet Target Price 172.7 21.1%
Analysts Target Price 177.2 24.3%
ValueRay Target Price 172.5 21%